Critical Appraisal of Filgotinib in the Treatment of Ulcerative Colitis: Current Evidence and Place in Therapy

Overview of attention for article published in Clinical and Experimental Gastroenterology, July 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 21 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 3 publications that cite this research output.

3

The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.

Intestinal Inflammation and Regeneration–Interdigitating Processes Controlled by Dietary Lipids in Inflammatory Bowel Disease

Article in International Journal of Molecular Sciences (January 2024)

The Role of Filgotinib in Ulcerative Colitis and Crohn’s Disease

Article in Immunotherapy (November 2023)

Dual Impact of Dietary Lipids on Inflammatory Bowel Disease: A Two-Edged Sword

Preprint in Preprints.org (November 2023)